Tnf Pharmaceuticals, Inc. (QCLS) SEC Filings — 2024
27 SEC filings for Tnf Pharmaceuticals, Inc. (QCLS) in 2024.
Filings
- TNF Pharmaceuticals Files 8-K: Director Changes & More — 8-K · Nov 26, 2024
- Tnf Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- TNF Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- TNF Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Nov 1, 2024
- TNF Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — 8-K · Oct 7, 2024
- TNF Pharmaceuticals Files 8-K on Accountant Change — 8-K · Oct 4, 2024
- TNF Pharmaceuticals Files 8-K on Shareholder Nominations — 8-K · Sep 23, 2024
- TNF Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 19, 2024
- TNF Pharmaceuticals Files 8-K on Material Agreement — 8-K · Aug 14, 2024
- TNF Pharmaceuticals Changes Fiscal Year End — 8-K · Jul 26, 2024
- MyMD Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Jul 1, 2024
- MyMD Pharmaceuticals Files 8-K on Security Holder Rights — 8-K · Jun 24, 2024
- MyMD Pharmaceuticals Files 8-K Amendment — 8-K/A · Jun 20, 2024
- MyMD Pharmaceuticals Announces Corporate Changes — 8-K · Jun 17, 2024
- PharmaCyte Biotech Files SC 13D for MyMD Pharmaceuticals — SC 13D · May 30, 2024
- MyMD Pharmaceuticals Files 8-K on Security Holder Rights — 8-K · May 23, 2024
- MyMD Pharmaceuticals Files 8-K: Agreements, Equity Sales, Bylaw Changes — 8-K · May 21, 2024
- MyMD Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- MyMD Pharmaceuticals Board Changes — 8-K · Apr 18, 2024
- MyMD Pharmaceuticals Reports Material Events and Officer Changes — 8-K · Apr 8, 2024
- MyMD Pharmaceuticals, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
- MyMD Pharmaceuticals Files 8-K Amendment — 8-K/A · Mar 26, 2024
- MyMD Pharmaceuticals Files 8-K: Material Agreements & Bylaw Changes — 8-K · Mar 7, 2024
- MyMD Pharmaceuticals Files 8-K — 8-K · Mar 5, 2024
- Mymd Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
- Mymd Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- MyMD Pharma Files 8-K on Shareholder Rights, Bylaw Changes — 8-K · Feb 13, 2024